Atlas Venture Fund XI, L.P.

Insider Buys Quantity –
5
2024-02-08SaleXilio Therapeutics, Inc.
XLO
10 percent owner
1,000
0.0034%
$0.64$640+74.17%
2024-01-12SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,100
0.0088%
$0.83$1,743+28.49%
2024-01-11SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,135
0.0083%
$0.87$1,857+12.64%
2021-12-14SaleIkena Oncology, Inc.
IKNA
10 percent owner
5,959
0.0217%
$14.00$83,426-63.59%
2021-12-13SaleIkena Oncology, Inc.
IKNA
10 percent owner
8,330
0.0307%
$14.64$121,951-64.74%
2021-12-10SaleIkena Oncology, Inc.
IKNA
10 percent owner
11,989
0.0457%
$15.03$180,195-64.33%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
187,500
0.6839%
$16.00$3M-76.08%
2021-06-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.24M
1.6574%
$6.44$8M-14.32%
2021-03-30PurchaseIkena Oncology, Inc.
IKNA
10 percent owner
125,000
2.0291%
$16.00$2M-49.34%
2021-02-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.48M
–
$0$0
2019-06-24PurchaseAkero Therapeutics, Inc.
AKRO
10 percent owner
540,000
13.8839%
$16.00$8.64M+13.18%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us